CR8537A - Moduladores de HM74 de Oxidecahidronaftaleno - Google Patents
Moduladores de HM74 de OxidecahidronaftalenoInfo
- Publication number
- CR8537A CR8537A CR8537A CR8537A CR8537A CR 8537 A CR8537 A CR 8537A CR 8537 A CR8537 A CR 8537A CR 8537 A CR8537 A CR 8537A CR 8537 A CR8537 A CR 8537A
- Authority
- CR
- Costa Rica
- Prior art keywords
- oxidecahydronaphthalene
- modulators
- oxidecalin
- molecules
- host cells
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Pyrrole Compounds (AREA)
- Pyrane Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Se usaron celulas hospedantes que expresan HM74 para obtener moleculas de tipo oxidecalina con actividad agonista, que tienen la formula estructural que se indica.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54601204P | 2004-02-20 | 2004-02-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR8537A true CR8537A (es) | 2007-03-05 |
Family
ID=34910747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR8537A CR8537A (es) | 2004-02-20 | 2006-07-26 | Moduladores de HM74 de Oxidecahidronaftaleno |
Country Status (21)
Country | Link |
---|---|
US (2) | US7264937B2 (es) |
EP (1) | EP1718293A1 (es) |
JP (1) | JP2007526917A (es) |
KR (1) | KR101145693B1 (es) |
CN (1) | CN1929833A (es) |
AR (1) | AR047708A1 (es) |
AU (1) | AU2005216878B2 (es) |
BR (1) | BRPI0507916A (es) |
CA (1) | CA2556757C (es) |
CR (1) | CR8537A (es) |
EC (1) | ECSP066776A (es) |
IL (1) | IL177106A (es) |
MA (1) | MA28368A1 (es) |
ME (2) | MEP17008A (es) |
NO (1) | NO20064214L (es) |
RS (1) | RS20060472A (es) |
RU (1) | RU2006133539A (es) |
TN (1) | TNSN06235A1 (es) |
TW (1) | TWI354552B (es) |
WO (1) | WO2005082352A1 (es) |
ZA (1) | ZA200606687B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1603585A2 (en) * | 2003-03-14 | 2005-12-14 | Bristol-Myers Squibb Company | Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74 |
ES2435790T3 (es) | 2004-12-03 | 2013-12-23 | Intervet International B.V. | Piperazinas sustituidas como antagonistas de CB1 |
CA2637565A1 (en) * | 2006-01-18 | 2007-07-26 | Schering Corporation | Cannibinoid receptor modulators |
WO2008130616A2 (en) * | 2007-04-19 | 2008-10-30 | Schering Corporation | Diaryl morpholines as cb1 modulators |
KR20100051625A (ko) * | 2007-06-28 | 2010-05-17 | 인터벳 인터내셔널 비.브이. | Cb1 길항제로서의 치환된 피페라진 |
EP2170847A2 (en) * | 2007-06-28 | 2010-04-07 | Intervet International BV | Substituted piperazines as cb1 antagonists |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US5674908A (en) * | 1993-12-20 | 1997-10-07 | Life Technologies, Inc. | Highly packed polycationic ammonium, sulfonium and phosphonium lipids |
DE19624154A1 (de) | 1996-06-18 | 1998-01-08 | Hoechst Ag | Ringannelierte Dihydropyrane, Verfahren zur Herstellung sowie deren Verwendung |
US6555339B1 (en) | 1997-04-14 | 2003-04-29 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human protein-coupled receptors |
AU7966098A (en) * | 1997-06-12 | 1998-12-30 | Smithkline Beecham Corporation | Hm74a receptor |
GB0021484D0 (en) * | 2000-09-01 | 2000-10-18 | Boehringer Ingelheim Pharma | Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
-
2005
- 2005-02-10 AU AU2005216878A patent/AU2005216878B2/en not_active Ceased
- 2005-02-10 JP JP2006554127A patent/JP2007526917A/ja active Pending
- 2005-02-10 BR BRPI0507916-0A patent/BRPI0507916A/pt active Search and Examination
- 2005-02-10 ME MEP-170/08A patent/MEP17008A/xx unknown
- 2005-02-10 WO PCT/US2005/004095 patent/WO2005082352A1/en not_active Application Discontinuation
- 2005-02-10 KR KR1020067016693A patent/KR101145693B1/ko not_active IP Right Cessation
- 2005-02-10 EP EP05713199A patent/EP1718293A1/en not_active Withdrawn
- 2005-02-10 CA CA2556757A patent/CA2556757C/en not_active Expired - Fee Related
- 2005-02-10 ME MEP-2008-170A patent/ME00059B/me unknown
- 2005-02-10 RU RU2006133539/04A patent/RU2006133539A/ru not_active Application Discontinuation
- 2005-02-10 RS RSP-2006/0472A patent/RS20060472A/sr unknown
- 2005-02-10 CN CNA2005800075098A patent/CN1929833A/zh active Pending
- 2005-02-14 US US11/057,263 patent/US7264937B2/en active Active
- 2005-02-18 TW TW094104732A patent/TWI354552B/zh not_active IP Right Cessation
- 2005-02-18 AR ARP050100595A patent/AR047708A1/es unknown
-
2006
- 2006-07-26 CR CR8537A patent/CR8537A/es not_active Application Discontinuation
- 2006-07-26 IL IL177106A patent/IL177106A/en not_active IP Right Cessation
- 2006-07-28 TN TNP2006000235A patent/TNSN06235A1/en unknown
- 2006-08-11 ZA ZA200606687A patent/ZA200606687B/xx unknown
- 2006-08-18 EC EC2006006776A patent/ECSP066776A/es unknown
- 2006-08-24 MA MA29288A patent/MA28368A1/fr unknown
- 2006-09-18 NO NO20064214A patent/NO20064214L/no not_active Application Discontinuation
-
2007
- 2007-08-30 US US11/847,370 patent/US20080045586A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR20060127982A (ko) | 2006-12-13 |
US20050187263A1 (en) | 2005-08-25 |
MA28368A1 (fr) | 2006-12-01 |
ME00059B (me) | 2010-06-10 |
EP1718293A1 (en) | 2006-11-08 |
MEP17008A (en) | 2010-06-10 |
US7264937B2 (en) | 2007-09-04 |
BRPI0507916A (pt) | 2007-07-10 |
AR047708A1 (es) | 2006-02-08 |
RS20060472A (en) | 2008-11-28 |
AU2005216878B2 (en) | 2010-06-17 |
IL177106A0 (en) | 2006-12-10 |
CN1929833A (zh) | 2007-03-14 |
IL177106A (en) | 2012-03-29 |
CA2556757A1 (en) | 2005-09-09 |
TNSN06235A1 (en) | 2007-12-03 |
TWI354552B (en) | 2011-12-21 |
ECSP066776A (es) | 2006-11-16 |
AU2005216878A1 (en) | 2005-09-09 |
NO20064214L (no) | 2006-09-18 |
TW200539864A (en) | 2005-12-16 |
ZA200606687B (en) | 2008-02-27 |
US20080045586A1 (en) | 2008-02-21 |
CA2556757C (en) | 2011-05-03 |
RU2006133539A (ru) | 2008-03-27 |
KR101145693B1 (ko) | 2012-05-25 |
JP2007526917A (ja) | 2007-09-20 |
WO2005082352A1 (en) | 2005-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0811993A2 (pt) | " hetarilanilinas como moduladores para beta-amiloide ". | |
BRPI0814593A2 (pt) | Composto, composição farmacêutica que o contém e uso do composto. | |
GT200600112A (es) | Composiciiones de tigeciclina y metodos de preparacion | |
BRPI0817475A2 (pt) | meio legível por computador. | |
BRPI0810744A2 (pt) | Moléculas absorventes de oxigênio, objetos que as contêm, e métodos de sua utilização | |
CL2008001656A1 (es) | Anticuerpo anti-c3b; composicion farmaceutica que lo comprende, y su uso para prevenir o tratar un trastorno asociado con el complemento; kit que lo contiene. | |
ECSP088461A (es) | Composiciones farmacéuticas que contienen buprenorfina | |
CR11548A (es) | Azolilmetiloxiranos, su uso y agentes que los contienen | |
CR9786A (es) | Compuestos de bencimidazol-tiofeno | |
CL2007002971A1 (es) | Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras. | |
CR8528A (es) | Derivados de furosemida como moduladores de hm74 y su uso para el tratamiento de la inflamacion | |
DE502005003251D1 (de) | Verwendung von menadione zur verstärkung der wirksamkeit von agrochemikalien | |
CL2008002041A1 (es) | Compuestos derivados de piperidina; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar ansiedad. | |
CL2008001393A1 (es) | Compuestos derivados de dihidroquinonas y dihidronaftiridinas, inhibidores de jnk; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar artritis reumatoide, asma, diabetes tipo 2, alzheimer, enfermedad de parkinson, hiperproliferacion celular. | |
CL2007002970A1 (es) | Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras. | |
CR8537A (es) | Moduladores de HM74 de Oxidecahidronaftaleno | |
CL2011000268A1 (es) | Uso de dronedarona para preparar un medicamento util en la prevencion del ictus o ataque isquemico transitorio. | |
CR9853A (es) | Compuestos de exemestano (s)-6-metiloxaalquilo y metodos relacionados con su utilizacion | |
AR055394A1 (es) | Polipeptidos con actividad antimicrobiana y polinucleotidos que los codifican | |
PA8845301A1 (es) | Polipéptidos que tienen actividad antimicrobiana | |
AR073871A1 (es) | Intermediario de fulvestran | |
EA201000864A1 (ru) | Фенилоксетанильные производные | |
BRPI0907797A2 (pt) | Novo uso de 3,3'-diindolimetano | |
FR2911496B1 (fr) | Emulsion eau-dans-huile solide utilisable en cosmetique. | |
ATE537816T1 (de) | Leflunomid enthaltende pharmazeutische zusammensetzungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |